Dealing with the high-risk potential of COVID-19 cross-infection in dental practice
Heribertus Dedy Kusuma Yulianto(1), Nunuk Purwanti(2), Trianna Wahyu Utami(3), Anne Handrini Dewi(4), Dyah Listyarifah(5), Intan Ruspita(6), Asikin Nur(7), Heni Susilowati(8*)
(1) Department of Dental Biomedical Sciences, Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta Integrated Research Laboratory, Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta
(2) Department of Dental Biomedical Sciences, Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta Integrated Research Laboratory, Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta
(3) Department of Dental Biomedical Sciences, Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta Integrated Research Laboratory, Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta
(4) Department of Dental Biomedical Sciences, Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta Integrated Research Laboratory, Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta
(5) Department of Dental Biomedical Sciences, Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta Integrated Research Laboratory, Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta
(6) Department of Prosthodontics, Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta Integrated Research Laboratory, Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta
(7) Department of Dental Biomedical Sciences, Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta Integrated Research Laboratory, Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta
(8) Department of Oral Biology, Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta Integrated Research Laboratory, Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta
(*) Corresponding Author
Abstract
Keywords
Full Text:
PDFReferences
1. Gugus Tugas Percepatan Penanganan COVID-19. Data sebaran. https://covid19.
go.id/. Accessed May 27, 2020.
2. Kemenkes. Pedoman pencegahan dan pengendalian corona virus disease
(COVID-19).; 2020. Diunduh dari: https://infeksiemerging.kemkes.go.id/downloads/?dl_cat=0&dl_search=pedoman+dan+pencegahan+covid#.Xs1qXGgzbIU pada 27 May 2020.
3. Dar Odeh N, Babkair H, Abu-Hammad S, Borzangy S, Abu-Hammad A, Abu-Hammad O. COVID-19: Present and future challenges for dental practice. Int J Environ Res Public Health. 2020; 17(9): 3151. doi: 10.3390/ijerph17093151
4. Lo Giudice R. The severe acute respiratory syndrome coronavirus-2 (SARS CoV-2) in dentistry. Management of biological risk in dental practice. Int J Environ Res Public Health. 2020; 17(9): 3067. doi: 10.3390/ijerph17093067
5. Dawood AA. Mutated COVID-19 may foretell a great risk for mankind in the future. New Microbes New Infect. 2020; 35: 100673.
doi: 10.1016/j.nmni.2020.100673
6. Ziegler CGK, Allon SJ, Nyquist SK, et al. SARS-CoV-2 receptor ACE2 is an interferonstimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell. 2020; 181(5): 1016-1035. e19. doi: 10.1016/j.cell.2020.04.035
7. Flor. J. Surviving COVID-19 pneumonia at home: COVID case #1906. Philipp J
Otolaryngol Head Neck Surg. 2020; 35(1): 78-79. doi: 10.32412/pjohns.v35i1.1259
8. Actor JK. Humoral Immunity. In: Elsevier’s Integrated Review Immunology and
Microbiology. Elsevier; 2012: 17-24. doi: 10.1016/B978-0-323-07447-6.00003-X
9. Xu X, Chen P, Wang J, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci. 2020; 63(3): 457-460. doi: 10.1007/s11427-020-1637-5
10. Tay MZ, Poh CM, Rénia L, MacAry PA, Ng LFP. The trinity of COVID-19: immunity,
inflammation and intervention. Nat Rev Immunol. 2020; 20(6): 363-374.
doi: 10.1038/s41577-020-0311-8
11. Li Z, Yi Y, Luo X, et al. Development and clinical application of a rapid IgM‐IgG
combined antibody test for SARS‐CoV‐2 infection diagnosis. J Med Virol. 2020: 1-7.
doi: 10.1002/jmv.25727
12. Racine R, Winslow GM. IgM in microbial infections: taken for granted? Immunol Lett. 2009; 125(2): 79-85. doi: 10.1016/j.imlet.2009.06.003
13. Shen C, Zhang M, Chen Y, et al. An IgM antibody targeting the receptor binding site of influenza B blocks viral infection with great breadth and potency. Theranostics. 2019; 9(1): 210-231. doi: 10.7150/thno.28434
14. Becerra-Flores M, Cardozo T. SARS-CoV-2 viral spike G614 mutation exhibits higher case fatality rate. Int J Clin Pract. 2020. doi: 10.1111/ijcp.13525
15. World Health Association (WHO). Coronavirus disease 2019 (covid-19) situation report – 73.; 2020. https://www.who.int/docs/default-source/coronavirus/situationreports/20200402-sitrep-73-covid-19.pdf?sfvrsn=5ae25bc7_6. Accessed May 28, 2020.
16. Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: A review. Clin Immunol. 2020; 215: 108427. doi: 10.1016/j.clim.2020.108427
17. Butowt R, Bilinska K. SARS-CoV-2: Olfaction, brain infection, and the urgent need for clinical samples allowing earlier virus detection. ACS Chem Neurosci. 2020; 11(9): 1200-1203. doi: 10.1021/acschemneuro.0c00172
18. Qian Z, Travanty EA, Oko L, et al. Innate immune response of human alveolar type II cells infected with severe acute respiratory syndrome–coronavirus. Am J Respir Cell Mol Biol. 2013; 48(6): 742-748. doi: 10.1165/rcmb.2012-0339OC
19. Jin Y, Yang H, Ji W, et al. Virology, epidemiology, pathogenesis, and control of COVID-19. Viruses. 2020; 12(4): 372. doi: 10.3390/v12040372
20. Zou X, Chen K, Zou J, Han P, Hao J, Han Z. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med. 2020; 14(2): 185-192. doi: 10.1007/s11684-020-0754-0
21. Li J, Fan J-G. Characteristics and mechanism of liver injury in 2019 coronavirus disease. J Clin Transl Hepatol. 2020; 8(1): 1-5. doi: 10.14218/JCTH.2020.00019
22. Das G, Mukherjee N, Ghosh S. Neurological insights of COVID-19 pandemic. ACS Chem Neurosci. 2020; 11(9): 1206-1209. doi: 10.1021/acschemneuro.0c00201
23. Ahmad I, Rathore FA. Neurological manifestations and complications of COVID-19: A literature review. J Clin Neurosci. 2020. doi: 10.1016/j.jocn.2020.05.017
24. Akhmerov A, Marbán E. COVID-19 and the heart. Circ Res. 2020; 126(10): 1443-1455. doi: 10.1161/CIRCRESAHA.120.317055
25. Inciardi RM, Lupi L, Zaccone G, et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020. doi: 10.1001/jamacardio.2020.1096
26. Kang Y, Chen T, Mui D, et al. Cardiovascular manifestations and treatment considerations in COVID -19. Heart. 2020: heartjnl-2020-317056.
doi: 10.1136/heartjnl-2020-317056
27. Carreras‐Presas CM, Sánchez JA, López‐Sánchez AF, Jané‐Salas E, Pérez MLS.
Oral vesiculobullous lesions associated with SARS‐CoV‐2 infection. Oral Dis. 2020.
doi: 10.1111/odi.13382
28. Xu H, Zhong L, Deng J, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 2020; 12(1): 8. doi: 10.1038/s41368-020-0074-x
29. Peng X, Xu X, Li Y, Cheng L, Zhou X, Ren B. Transmission routes of 2019-nCoV and controls in dental practice. Int J Oral Sci. 2020; 12(1): 1-6. doi: 10.1038/s41368-020-0075-9
30. Lange C, Wolf J, Auw-Haedrich C, et al. Expression of the COVID-19 receptor ACE2 in the human conjunctiva. J Med Virol. 2020. doi: 10.1002/jmv.25981
31. Ather A, Patel B, Ruparel NB, Diogenes A, Hargreaves KM. Coronavirus Disease 19 (COVID-19): implications for clinical dental care. J Endod. 2020; 46(5): 584-595.
doi: 10.1016/j.joen.2020.03.008
32. Gerberding JL, Director David Fleming MW, Snider DE, et al. Morbidity and mortality weekly report guideline for hand hygiene in health-care settings recommendations of the healthcare infection control practices advisory committee and the HICPAC/SHEA/APIC/IDSA hand hygiene. Task Force Centers for Disease
Control and Prevention. 2002; 51.
33. Centers for Disease Control and Prevention (CDC). Infection control: Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2). https://www.cdc.gov/coronavirus/ 2019-ncov/hcp/infection-control-recommendations.html. Accessed May 29, 2020.
34. Centers for Disease Control and Prevention (CDC). Social Distancing, Quarantine, and Isolation. https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/socialdistancing.html. Accessed May 29, 2020.
35. Centers for Disease Control and Prevention (CDC). Sequence for putting on personal protective equipment (PPE). https://www.cdc.gov/hai/pdfs/ppe/ppe-sequence.pdf. Accessed May 29, 2020.
36. Centers for Disease Control and Prevention (CDC). Interim Guidance: Healthcare Professionals 2019-nCoV | CDC. https://www.cdc.gov/coronavirus/2019-nCoV/hcp/clinicalcriteria.html. Accessed May 29, 2020.
37. Ge Z, Yang L, Xia J, Fu X, Zhang Y. Possible aerosol transmission of COVID-19 and special precautions in dentistry. J Zhejiang Univ B. 2020; 21(5): 361-368.
doi: 10.1631/jzus.B2010010
38. Babu B, Gupta S, Sahni V. Aerosol box for dentistry. Br Dent J. 2020; 228(9): 660. doi: 10.1038/s41415-020-1598-3
39. American Dental Association (ADA). Dental unit water lines. https://success.ada.org/en/practice-management/guidelines-for-practicesuccess/
gps-managing-regulatory/04_dentalunit-water-lines. Accessed June 5, 2020.
40. Harrel SK, Molinari J. Aerosols and splatter in dentistry. J Am Dent Assoc. 2004; 135(4): 429-437. doi: 10.14219/jada.archive.2004.0207
41. FDI World Dental Federation. COVID-19 Outbreak: Guidance for Oral Pealth
professionals. https://www.fdiworlddental.org/covid-19-outbreak-guidance-for-oral-healthprofessionals. Accessed May 29, 2020.
42. American Dental Association (ADA). Coronavirus (COVID-19) Center for Dentists. https://success.ada.org/en/-practice-management/patients infectious-diseases-2019-novel coronavirus?utm_source=jadaorg&utm medium=cov19page&utm_content=cv-mvresourcecenter&utm_campaign=covid-19. Accessed May 29, 2020.
43. World Health Association (WHO). Infection Prevention and Control. https://www.who.int/emergencies/diseases/novel-coronavirus-
2019/technical-guidance/infection-prevention-andcontrol. Accessed May 29, 2020.
44. Scottish Dental Clinical Effectiveness Programme (SDCEP). Management of
acute dental problems during COVID-19 pandemic. www.sdcep.org.uk. Accessed May 29, 2020.
45. Mady LJ, Kubik MW, Baddour K, Snyderman CH, Rowan NR. Consideration of povidoneiodine as a public health intervention for COVID-19: Utilization as “Personal Protective Equipment” for frontline providers exposed in high-risk head and neck and skull base oncology care. Oral Oncol. 2020; 105: 104724.
doi:10.1016/j.oraloncology.2020.104724
46. Eggers M, Koburger-Janssen T, Eickmann M, Zorn J. In vitro bactericidal and virucidal efficacy of povidone-iodine gargle/mouthwash against respiratory and oral tract pathogens. Infect Dis Ther. 2018; 7(2): 249-259. doi: 10.1007/s40121-018-0200-7
47. Challacombe SJ, Kirk-Bayley J, Sunkaraneni VS, Combes J. Povidone iodine. Br Dent J. 2020; 228(9): 656-657. doi: 10.1038/s41415-020-1589-4
48. Pattanshetty S, Narayana A, Radhakrishnan R. Povidone‐iodine gargle as a prophylactic intervention to interrupt the transmission of SARS‐CoV‐2. Oral Dis. 2020. doi: 10.1111/odi.13378
49. Parhar HS, Tasche K, Brody RM, et al. Topical preparations to reduce SARS‐CoV‐2 aerosolization in head and neck mucosal surgery. Head Neck. 2020; 42(6): 1268-1272. doi: 10.1002/hed.26200
50. HalodineTM nasal and oral antiseptics show rapid antiviral activity against SARS-CoV-2 (COVID-19). https://www.prnewswire.com/news-releases/halodine-nasal-and-oralantiseptics-show-rapid-antiviral-activityagainst-sars-cov-2--covid-19-301059003. html. Accessed May 29, 2020.
51. Müller G, Kramer A. Comparative study of in vitro cytotoxicity of povidone-iodine in solution, in ointment or in a liposomal formulation (Repithel®) and selected antiseptics. Dermatology. 2006; 212(1): 91-93. doi: 10.1159/000090102
52. Kim JH, Rimmer J, Mrad N, Ahmadzada S, Harvey RJ. Betadine has a ciliotoxic effect on ciliated human respiratory cells. J Laryngol Otol. 2015; 129(S1): S45-S50.
doi: 10.1017/S0022215114002746
DOI: https://doi.org/10.22146/majkedgiind.56588
Article Metrics
Abstract views : 3895 | views : 4105Refbacks
- There are currently no refbacks.
Copyright (c) 2020 Majalah Kedokteran Gigi Indonesia
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.